SCHEMBL985624

SCHEMBL985624

O=C(Cn1c(=O)[nH]c(=O)c2[nH]cnc21)c1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PNP P00491 2/20 0.66
▸ PDE4A P27815 3/20 0.57
▸ ADORA2A P29274 3/20 0.57
▸ PDE4B Q07343 3/20 0.57
▸ PDE4C Q08493 3/20 0.57
▸ PDE4D Q08499 3/20 0.57
▸ ADORA3 P0DMS8 3/20 0.54
▸ ADORA2B P29275 3/20 0.54
▸ HPGD P15428 1/20 0.54
▸ ADORA1 P30542 1/20 0.54
▸ BLM P54132 1/20 0.54
▸ PDE3A Q14432 1/20 0.54
▸ HSD17B10 Q99714 1/20 0.54
▸ DAO P14920 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ MPO P05164 2/20 0.43
▸ TPO P07202 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19370607 0.80 PDE4A (0.64) PNPPDE4AADORA2APDE4BPDE4C
SCHEMBL9032111 0.80 PNP (1.00) PNPPDE4AADORA2APDE4BPDE4C
SCHEMBL25834247 0.80 PDE4A (0.68) PNPPDE4AADORA2APDE4BPDE4C
SCHEMBL985620 0.80 ADORA2B (0.63) PNPPDE4AADORA2APDE4BPDE4C
SCHEMBL3699117 0.74 PDE4A (0.73) PNPPDE4AADORA2APDE4BPDE4C
SCHEMBL7466316 0.73 ADORA2A (1.00) PNPPDE4AADORA2APDE4BPDE4C
SCHEMBL5515323 0.73 ADORA2A (0.71) PNPPDE4AADORA2APDE4BPDE4C
SCHEMBL6267430 0.72 PNP (0.45) PNPPDE4APDE4BPDE4CPDE4D
SCHEMBL30488609 0.71 PDE4A (0.74) PNPPDE4AADORA2APDE4BPDE4C
SCHEMBL27859109 0.71 PNP (0.79) PNPPDE4AADORA2APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011005929-A1 PIPERIDINE DERIVATIVE AND ITS USE FOR THE TREATMENT OF DIABETS AND OBESITY ARENA PHARMACEUTICALS, INC. (US) 2011-01-13 — — WO claimed
Send feedback